rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Veralto Corp

VLTO · NYSE

Health CareLife-science toolsIn trend

VLTO stood above a rising 150-day average in 5 of the last 52 weekly readings, including each of the last 4 weeks. It is 10.4% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
4 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$6.0M
Officials’ trades on record
23
Institutions holding
921 (-55)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

23 disclosed lines: House 10, Senate 4, executive 9; 6 people.

WhoDidAmountTraded
Kevin Hern House: U.S. House ClerkOK01soldjoint$1k–$15k21 Aug 2026filed 1 Sep 2026
Kevin Hern House: U.S. House ClerkOK01soldjoint$1k–$15k14 Aug 2026filed 1 Sep 2026
Kevin Hern House: U.S. House ClerkOK01soldjoint$1k–$15k10 Aug 2026filed 1 Sep 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k24 Jun 2026filed 2 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k23 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k12 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k3 Jun 2026filed 22 Aug 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k11 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k1 May 2026filed 8 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k28 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k27 Apr 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k13 Apr 2026filed 8 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months6
Buyers · sellers0 · 5
WhoDidSharesTraded
Surekha TrivediSVP, Strategy & Sustainabilitysold986at $97.0517 Aug 2026filed 19 Aug 2026
Jennifer HoneycuttPresident and CEOsold7,097at $101.5229 Jul 2026filed 31 Jul 2026
Jennifer HoneycuttPresident and CEOsold7,097at $95.0017 Jul 2026filed 21 Jul 2026
Bernard M. SkeeteChief Accounting Officersold300at $88.211 May 2026filed 5 May 2026
Melissa KapitySVP, Water Qualitysold5,096at $96.6027 Feb 2026filed 3 Mar 2026
Melissa KapitySVP, Water Qualitysold2,639at $96.6027 Feb 2026filed 3 Mar 2026
Melissa KapitySVP, Water Qualitysold7,105at $96.6027 Feb 2026filed 3 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders921-55 on the quarter
New · exited82 · 138
Reported value$19.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 202622,647,953$2.0B-2,281,597−9.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202616,043,210$1.4B+336,761+2.1%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202612,149,926$1.1B+368,453+3.1%
STATE STREET CORPadded · filed 7 Aug 202611,131,069$988.5M+205,603+1.9%
FIRST TRUST ADVISORS LPadded · filed 11 Aug 20268,190,187$726.3M+2,039,799+33.2%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 20267,389,874$653.0M-104,669−1.4%
Invesco Ltd.added · filed 14 Aug 20265,536,282$491.0M+440,126+8.6%
Impax Asset Management Group plcadded · filed 11 Aug 20265,186,589$459.9M+1,810,492+53.6%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20264,041,035$358.4M+744,914+22.6%
ALLIANCEBERNSTEIN L.P.reduced · filed 14 Aug 20263,735,658$330.3M-180,708−4.6%
30 Sep 2023 – 30 Jun 2026
129564998Sep 23Jun 24Mar 25Sep 25Jun 26

Everyone who traded it

Kevin Hern HouseOK01 · last 21 Aug 20260 · 3
Surekha Trivedi Company insiderSVP, Strategy & Sustainability · last 17 Aug 20260 · 10
Jennifer Honeycutt Company insiderPresident and CEO · last 29 Jul 20260 · 9
Cindy L. Wallis-Lage Company insiderDirector · last 24 Jul 20260 · 0
Heath A. Mitts Company insiderDirector · last 24 Jul 20261 · 0
Thomas Williams Company insiderDirector · last 24 Jul 20260 · 0
Daniel L. Comas Company insiderDirector · last 15 Jul 20260 · 0
Francoise Colpron Company insiderDirector · last 15 Jul 20260 · 0
John T. Schwieters Company insiderDirector · last 15 Jul 20260 · 0
Linda Filler Company insiderDirector · last 15 Jul 20260 · 0
Sameer Ralhan Company insiderSVP, Chief Financial Officer · last 15 Jul 20260 · 0
Shyam Kambeyanda Company insiderDirector · last 15 Jul 20260 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

Awards1
Total$1.4M
Latest29 Sep 2026

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202559.9%
Operating profit marginFY 2025 · to 31 Dec 202523.2%
Free cash flow marginFY 2025 · to 31 Dec 202518.4%
Return on capital employedFY 2025 · to 31 Dec 202522.7%
Cash conversionFY 2025 · to 31 Dec 2025115%
Debt to equityFY 2025 · to 31 Dec 20251.09×
Research spendFY 2025 · to 31 Dec 20254.8%
Share count trendFY 2025 · to 13 Feb 2026-0.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.0B
Free cash flowFY 2025 · to 31 Dec 2025$1.0B

Analyst forecasts

No analyst forecasts yet.